EUVIMEDEUVIMED entdecken
Crossref

Tumor permeable self-delivery nanodrug targeting mitochondria for enhanced chemotherapy

Guiping Yuan, Yifan Zhang, Shiqun Shao, Zhuxian Zhou, Jianbin Tang, Jiajia Xiang, Youqing Shen

Journal of Controlled Release · 2023-09 · 361 · 792-802

DOI: 10.1016/j.jconrel.2023.08.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-09. Verfasst von Guiping Yuan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University,…. Hauptthemen laut MEDLINE: Prodrugs, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Key Research and Development Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug self-delivery systems (DSDSs) have been extensively exploited to enhance drug loading capacity and avoid excipient-related toxicity issues. However, deficient tumor targeting, inferior tumor permeability, prominent burst release, and nonspecific subcellular distribution remain major obstacles. Herein, we reported a ROS-responsive amphiphilic prodrug (CPT-S-NO) synthesized by the conjugation of zwitterionic tertiary amine-oxide (TAO) moiety and hydrophobic camptothecin (CPT) through a thioether linkage, which formed a nanoparticulate DSDS in an aqueous solution. CPT-S-NO, compared with CPT-11 and the water-soluble TAO-modified CPT prodrug (CPT-NO), exhibited prolonged blood circulation, enhanced tumor accumulation, deep tumor penetration, efficient mitochondrial targeting, and ROS-activated drug release to induce mitochondrial dysfunction, corporately conducing to the superior antitumor efficacy in vivo. This TAO decoration strategy promises potential applications in designing multipotent DSDSs for various drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsNeoplasmsNanoparticlesHumansReactive Oxygen SpeciesMitochondriaOxidesWater

Stichwörter der Autor:innen

Active tumor penetrationCamptothecin prodrugDrug self-delivery systemsMitochondrial targetingTertiary amine-oxide

Substanzen

ProdrugsReactive Oxygen SpeciesOxidesWater

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China; Key Laboratory of Biomass Chemical Engineerin…

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Key Research and Development Program of Zhejiang Province

Zitieren

APA

Yuan, G., Zhang, Y., Shao, S., Zhou, Z., Tang, J., Xiang, J., & Shen, Y. (2023). Tumor permeable self-delivery nanodrug targeting mitochondria for enhanced chemotherapy. Journal of Controlled Release, 361, 792-802. https://doi.org/10.1016/j.jconrel.2023.08.032

Vancouver

Yuan G, Zhang Y, Shao S, Zhou Z, Tang J, Xiang J, et al. Tumor permeable self-delivery nanodrug targeting mitochondria for enhanced chemotherapy. Journal of Controlled Release. 2023;361:792-802. doi:10.1016/j.jconrel.2023.08.032

BibTeX
@article{Yuan2023,
  author = {Yuan, Guiping and Zhang, Yifan and Shao, Shiqun and Zhou, Zhuxian and Tang, Jianbin and Xiang, Jiajia and Shen, Youqing},
  title = {Tumor permeable self-delivery nanodrug targeting mitochondria for enhanced chemotherapy},
  journal = {Journal of Controlled Release},
  year = {2023},
  volume = {361},
  pages = {792--802},
  doi = {10.1016/j.jconrel.2023.08.032}
}
Kostenlos starten →